Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease

OBJECTIVE: In this study, we assessed plasma biomarkers to identify cognitive impairment in Parkinson’s disease (PD) patients by applying ultra-sensitive immunomagnetic reduction-based immunoassay (IMR). METHODS: The study enrolled 60 PD patients and 28 age- and sex-matched normal controls. Complete...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Nai-Ching, Chen, Hsiu-Ling, Li, Shau-Hsuan, Chang, Yen-Hsiang, Chen, Meng-Hsiang, Tsai, Nai-Wen, Yu, Chiun-Chieh, Yang, Shieh-Yueh, Lu, Cheng-Hsien, Lin, Wei-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198695/
https://www.ncbi.nlm.nih.gov/pubmed/32410983
http://dx.doi.org/10.3389/fnagi.2020.00112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198695/
https://www.ncbi.nlm.nih.gov/pubmed/32410983
http://dx.doi.org/10.3389/fnagi.2020.00112

Ejemplares similares